Trishula Therapeutics
trishulatx.comTrishula is a clinical stage company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody being studied in advanced cancers in multiple indications.
Something looks off?Open jobs at Trishula Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.